ArticlebioRxiv : the preprint server for biology2026
Bidirectional coupling among EMT, AXL-RB1 signaling and lineage switch drives resistance to osimertinib and worse clinical outcomes in NSCLC.
Shreya Vashista et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.